Profusa (PFSA) EBIT Growth (1y) (2023 - 2026)
Profusa (PFSA) EBIT Growth (1y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | -17.50% |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 49.06% |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 43.83% |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 24.81% |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 49.72% |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 13.00% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 57.74% |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 16.18% |
| 10 | Profusa | 121,921.34 | -253,078.66 | - | -181.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -181.32% |
| Dec 31, 2025 | -229.94% |
| Sep 30, 2025 | -1,868.18% |
| Jun 30, 2025 | -282.05% |
| Mar 31, 2025 | -202.44% |
| Dec 31, 2024 | -135.14% |
| Sep 30, 2024 | -280.22% |
| Jun 30, 2024 | 19.57% |
| Mar 31, 2024 | -6.11% |
| Dec 31, 2023 | -13.06% |
| Sep 30, 2023 | 28.27% |
| Jun 30, 2023 | -44.68% |
| Mar 31, 2023 | -83.66% |